greeksoup/ stock research

UnitedHealth Group (UNH) Q1 FY2026 earnings: revenue $111.7 billion, up 2.0% on the year

UnitedHealth Group Inc. (UNH) reported revenue of $111.7 billion for Q1 FY2026, the quarter ended 31 March 2026, up 2.0% on the same quarter a year earlier. Net income was $6.3 billion, down 0.2% on the year, and diluted earnings per share $6.90. The figures are the company's own, from the 10-Q it filed with the SEC on 5 May 2026.

Revenue
$111.7 billion
+2.0% on the year · -1.3% on the quarter
Q2 FY2024Q1 FY2026
Operating margin
8.0%
8.3% a year earlier
Q2 FY2024Q1 FY2026
Net income
$6.3 billion
-0.2% on the year · +62,700.0% on the quarter
Q2 FY2024Q1 FY2026
Diluted EPS
$6.90
+0.7% on the year · +68,900.0% on the quarter
Q2 FY2024Q1 FY2026

this quarterthe same quarter a year earlierHover a bar for its figure.

What management said

Guidance figures: 2 raised, 2 new, 1 kept.

  • Revenue rose 2% to $111.7 billion: Revenues were $111.7 billion, up from $109.6 billion a year earlier. Earnings from operations were $9.0 billion against $9.1 billion.
  • Medical care ratio down 90 basis points: The medical care ratio was 83.9%, compared with 84.8% a year earlier. The company cited cost management and favorable reserve development.
  • UnitedHealthcare margin rose to 6.6%: UnitedHealthcare revenues were $86.3 billion and earnings from operations were $5.7 billion. Management attributed the margin change mainly to repricing.
Read the earnings call summary

Income statement (profit and loss)

$ millionQ1 FY2026Q4 FY2025Q1 FY2025On the quarterOn the yearLast 8 quarters
Revenue111,721113,215109,575-1.3%+2.0%
Cost of revenue12,82312,68012,390+1.1%+3.5%
Gross profit98,898100,53597,185-1.6%+1.8%
Gross margin88.5%88.8%88.7%
Selling, general and administrative15,39016,99713,594-9.5%+13.2%
Operating income8,9903809,119+2,265.8%-1.4%
Operating margin8.0%0.3%8.3%
Interest expense955974998-2.0%-4.3%
Pre-tax income7,963-7208,106-1.8%
Income tax1,482-9381,632-9.2%
Effective tax rate18.6%n/a20.1%
Net income6,28010.06,292+62,700.0%-0.2%
Net margin5.6%0.0%5.7%
Diluted EPS$6.90$0.01$6.85+68,900.0%+0.7%
$ million except per share.
Read moreFourth quarters are the year less the first three quarters. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionQ1 FY2026Q4 FY2025Q1 FY2025On the quarterOn the yearLast 8 quarters
Operating cash flow8,9121,1085,456+704.3%+63.3%
Capital expenditure763948898-19.5%-15.0%
Free cash flow8,1491604,558+4,993.1%+78.8%
Free cash flow margin7.3%0.1%4.2%
Cash from investing-2,447-2,611-74.0
Cash from financing-2,992-1,03199.0
Depreciation and amortisation1,0291,1171,061-7.9%-3.0%
Share-based compensation348176375+97.7%-7.2%
Buybacks0.00.03,000
Dividends paid2,0052,0021,912+0.1%+4.9%
Dividend per share$2.21n/a$2.10+5.2%
Diluted shares, weighted910m910m918m0.0%-0.9%
Shares outstanding at period end908m906m910m+0.2%-0.2%

Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.

Balance sheet

$ millionQ1 FY2026Q4 FY2025Q1 FY2025On the quarterOn the yearLast 8 quarters
Shareholders' equity103,895100,090100,811+3.8%+3.1%
Redeemable equity1,4241,6084,358-11.4%-67.3%
Debt77,91778,38981,271-0.6%-4.1%
Other liabilities129,408129,494123,350-0.1%+4.9%
Total liabilities and equity312,644309,581309,790+1.0%+0.9%
Fixed assets10,66710,76210,734-0.9%-0.6%
Goodwill110,512110,499107,566+0.0%+2.7%
Intangible assets20,09320,47422,947-1.9%-12.4%
Investments60,01658,00755,437+3.5%+8.3%
Cash and equivalents28,00124,36530,717+14.9%-8.8%
Receivables26,58723,01826,936+15.5%-1.3%
Inventoryn/a3,300n/a
Other assets56,76859,15655,453-4.0%+2.4%
Total assets312,644309,581309,790+1.0%+0.9%

Questions

What was UnitedHealth Group's revenue in Q1 FY2026?

UnitedHealth Group (UNH) reported revenue of $111.7 billion for Q1 FY2026, the quarter ended 31 March 2026, up 2.0% on the same quarter a year earlier.

How much did UnitedHealth Group earn in Q1 FY2026?

Net income for Q1 FY2026 was $6.3 billion, down 0.2% on the year, and diluted earnings per share $6.90.

When did UnitedHealth Group report Q1 FY2026 results?

UnitedHealth Group filed its 10-Q for the quarter ended 31 March 2026 with the SEC on 5 May 2026.

Quarterly results, the last 20 quarters

Q4 FY2021 *Q1 FY2022Q2 FY2022Q3 FY2022Q4 FY2022 *Q1 FY2023Q2 FY2023Q3 FY2023Q4 FY2023 *Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024 *Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025 *Q1 FY2026Q2 FY2026Q3 FY2026
Revenue73,74380,14980,33280,89482,78791,93192,90392,36194,42799,79698,855100,820100,807109,575111,616113,161113,215111,721112,032112,694
Cost of revenue8,0008,4878,5968,3068,3149,4059,7489,42310,19411,05611,34011,83412,46412,39013,01912,56612,68012,82313,37513,707
Gross profit65,74371,66271,73672,58874,47382,52683,15582,93884,23388,74087,51588,98688,34397,18598,597100,595100,53598,89898,65798,987
Gross margin89%89%89%90%90%90%90%90%89%89%89%88%88%89%88%89%89%89%88%88%
SG&A11,27211,40111,70911,66313,00913,62513,80913,85513,33914,07713,16213,28012,49413,59413,77815,22316,99715,39014,26814,369
Operating income5,5416,9507,1327,4626,8918,0868,0578,5267,6897,9317,8758,7087,7739,1195,1504,3153808,9907,9916,563
Operating margin8%9%9%9%8%9%9%9%8%8%8%9%8%8%5%4%0%8%7%6%
Interest expense4314334675166767548288348308449851,0741,0039981,0271,003974955962963
Pre-tax income5,1106,5176,6656,9466,2157,3327,2297,6926,8591.05,6657,6146,7918,1064,0823,229-7207,9636,9685,524
Tax rate18%21%22%22%21%21%22%22%17%122200%22%18%15%20%12%21%n/a19%19%22%
Net income4,0715,0275,0705,2624,7615,6115,4745,8415,455-1,4094,2166,0555,5436,2923,4062,34810.06,2805,4844,110
Net margin6%6%6%7%6%6%6%6%6%-1%4%6%5%6%3%2%0%6%5%4%
Diluted EPS$4.26$5.27$5.34$5.55$5.03$5.95$5.82$6.24$5.83-$1.53$4.54$6.51$5.98$6.85$3.74$2.59$0.01$6.90$6.04$4.56
Operating cash flow3,2185,3196,87118,549-4,53316,32711,0326,902-5,1931,1446,74613,9452,3695,4567,1885,9451,1088,91211,0525,123
Capital expenditure695555657724866760829838959743853991912898886890948763799859
Free cash flow2,5234,7646,21417,825-5,39915,56710,2036,064-6,1524015,89312,9541,4574,5586,3025,0551608,14910,2534,264
Buybacks1,0502,5002,5001,0001,0002,0003,0001,5001,5003,0720.09564,9723,0002,5450.00.00.01,6463,385
Dividends paid1,3651,3631,5451,5421,5411,5371,7471,7391,7381,7291,9351,9371,9321,9122,0002,0022,0022,0052,0872,078
Shares outstanding941m939m935m935m934m932m927m925m924m920m921m923m915m910m905m906m906m908m905m896m
Filing10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q
Each quarter as filed, linked to its filing.
Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS, and its diluted share count where shown, are from the company's results press release for that quarter, checked against the company's filed figures or a second data source. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

10-Q for the period ended 31 March 2026, filed 5 May 2026: the filing.